Browse experiments

Clear

First Previous 1 ... 8 9 10 11 12 ... 26 Next Last

Page 10 of 26 (2503 experiments total, 100 per page)

Experiment Paper Year Peptide RNA type Uptake confirmed In vitro functional effect Endosomal escape evidence In vivo Success class
EXP000925 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 BR2 (cancer-specific CPP) siRNA yes yes no no
EXP000926 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 R9 (poly-arginine CPP) siRNA yes yes no no
EXP000928 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 BR2 (cancer-specific CPP) siRNA no no no no
EXP000929 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 BR2 (cancer-specific CPP) siRNA no yes no no
EXP000930 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 R9 (poly-arginine CPP) siRNA no yes no no
EXP000932 VEGF siRNA Delivery by a Cancer-Specific Cell-Penetrating Peptide 2018 BR2 (cancer-specific CPP) siRNA no no no no
EXP000933 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 PF14 SCO yes yes no no
EXP000934 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 SCO yes no no no
EXP000935 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect1 SCO yes yes no no
EXP000936 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect2 SCO yes no no no
EXP000937 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect3 SCO yes yes no no
EXP000938 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect4 SCO yes no no no
EXP000939 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect5 SCO yes no no no
EXP000940 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect6 SCO yes no no no
EXP000941 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect7 SCO yes no no no
EXP000942 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect8 SCO yes no no no
EXP000943 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect9 SCO yes no no no
EXP000944 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 + PF14 SCO yes yes no no
EXP000945 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 PF14 ASO yes no no no
EXP000946 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect1 ASO yes yes no no
EXP000947 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect3 ASO yes yes no no
EXP000948 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect4 ASO yes yes no no
EXP000949 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect5 ASO yes yes no no
EXP000950 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect6 ASO yes yes no no
EXP000951 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect7 ASO yes yes no no
EXP000952 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect8 ASO yes yes no no
EXP000953 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect9 ASO yes yes no no
EXP000954 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 ASO yes yes no no
EXP000955 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 + PF14 ASO yes yes no no
EXP000956 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 PF14 ASO yes yes no no
EXP000957 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect1 ASO yes yes no no
EXP000958 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect3 ASO yes yes no no
EXP000959 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect4 ASO yes yes no no
EXP000960 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect5 ASO yes yes no no
EXP000961 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect6 ASO yes yes no no
EXP000962 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect7 ASO yes yes no no
EXP000963 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect8 ASO yes yes no no
EXP000964 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect9 ASO yes yes no no
EXP000965 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 ASO yes no no
EXP000966 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 + PF14 ASO yes yes no no
EXP000967 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 PF14 ASO yes no no no
EXP000968 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect1 ASO yes yes no no
EXP000969 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect3 ASO yes yes no no
EXP000970 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect4 ASO yes yes no no
EXP000971 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect5 ASO yes yes no no
EXP000972 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect6 ASO yes yes no no
EXP000973 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect7 ASO yes yes no no
EXP000974 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect8 ASO yes yes no no
EXP000975 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mitFect9 ASO yes yes no no
EXP000976 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 ASO yes yes no no
EXP000977 Intracellular delivery of therapeutic antisense oligonucleotides targeting mRNA… 2020 mtCPP1 + PF14 ASO yes yes no no
EXP000981 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 no no no no
EXP000982 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat no no no no
EXP000983 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 RNA aptamer + Cy5 DNA probe (aptamer–probe hybrid) yes no no no
EXP000984 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat RNA aptamer + Cy5 DNA probe (aptamer–probe hybrid) yes no no no
EXP000985 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 T7 RNA aptamer + Cy5 DNA probe (aptamer–probe hybrid) yes no no no
EXP000986 Enhanced target cell specificity and uptake of lipid nanoparticles using RNA ap… 2021 Tat RNA aptamer + Cy5 DNA probe (aptamer–probe hybrid) yes no no no
EXP000987 Thiol-Cyanobenzothiazole Ligation for the Efficient Preparation of Peptide-PNA … 2019 ApoE(140-150) CPP – thiol–maleimide linkage (C3) PNA (antisense oligonucleotide; 20-mer) no yes no no
EXP000988 Thiol-Cyanobenzothiazole Ligation for the Efficient Preparation of Peptide-PNA … 2019 ApoE(140-150) CPP – thiol–CBT linkage (C4) PNA (antisense oligonucleotide; 20-mer) no yes no no
EXP000989 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 plasmid DNA no yes no no
EXP000990 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 plasmid DNA no yes no no
EXP000991 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 plasmid DNA no yes no no
EXP000992 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10 (with hPP10-NLS-Cre protein) plasmid DNA no yes no no
EXP000993 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT plasmid DNA no yes no no
EXP000994 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT plasmid DNA no yes no no
EXP000995 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 TAT plasmid DNA no yes no no
EXP000996 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10-E3 siRNA no yes no no
EXP000997 Intracellular delivery of nucleic acid by cell‐permeable hPP10 peptide 2018 hPP10-E3 siRNA no yes no no
EXP000999 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF6 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001000 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001001 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF6 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001002 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001003 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001004 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Pal-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001005 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR3 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001006 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001007 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR5 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001008 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-KL4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001009 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-ST1 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001010 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Lau-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001011 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 PF14 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001012 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001013 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Pal-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001014 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-RXR3 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001015 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001016 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 STR5 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001017 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-KL4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001018 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 St-ST1 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001019 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Ac-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001020 Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oli… 2015 Myr-RXR4 PMO (phosphorodiamidate morpholino oligonucleotide; splice-switching) no yes no no
EXP001021 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) siRNA yes yes no no
EXP001022 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Tat(49–57) CPP (N3-CPP) siRNA yes yes no no
EXP001023 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) siRNA yes yes no no
EXP001024 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) (with Glu charge-reversal module) siRNA yes yes no no
EXP001025 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) siRNA no yes yes
EXP001026 A one-pot modular assembly strategy for triple-play enhanced cytosolic siRNA de… 2019 Octreotide (N3-Oct) + Tat(49–57) CPP (N3-CPP) (with Glu charge-reversal module) siRNA no yes yes
EXP001027 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 PMO (antimiR) no yes yes no
EXP001028 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2 PMO (antimiR) no yes yes
EXP001029 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC PMO (antimiR) no yes yes no
EXP001030 Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by pro… 2023 Pip9b2KC PMO (antimiR) no yes yes

First Previous 1 ... 8 9 10 11 12 ... 26 Next Last